CRI Lifetree

PRA Health Sciences becomes latest big CRO to launch IPO

Thursday, November 13, 2014 03:38 PM

PRA Health Sciences launched its initial public offering this morning, raising $306 million from the sale of nearly 17 million shares at $18 per share—below plans it announced in September to raise up to $375 million.

More... »

Quest Diagnostics

Bracket names Jeff Kinell CEO

Monday, October 6, 2014 06:54 AM

Bracket, a clinical trial specialty services provider, has announced the addition of Jeffrey W. Kinell as CEO and new member of its board of directors.

More... »


PRA to acquire CRI Lifetree, boosting global phase I presence

Wednesday, November 13, 2013 09:01 AM

PRA, a CRO based in Raleigh, N.C., intends to acquire privately held CRI Lifetree, a research organization that focuses on early stage, patient population studies.

More... »

CRI Lifetree appoints Craig-Rodriguez and Marcos to leadership team

Friday, September 28, 2012 02:59 PM

CRI Lifetree, a multi-therapeutic early stage research company, has strengthened its early phase leadership with the appointments of Alicia Craig-Rodriguez as chief operating officer and Jose Marcos as East Coast director of clinical operations. 

More... »

CRI Lifetree opens new early stage research facility

Tuesday, July 10, 2012 10:23 AM

CRI Lifetree, a specialized, multi-therapeutic early stage research company focused on pain, human abuse liability, psychiatry, neurology and diabetes, has opened a new state-of-the-art research facility in Marlton, N.J. The new site raises the company’s total bed count to 250 and adds capacity to conduct complex clinical trials.

More... »


CWWeekly

April 20

Christie Clinic, PMG Research's 12th clinical research site, expands its geographic reach north to Illinois

Clinipace acquires Accovion to expand European presence, following an infusion of equity that could lead to more deals

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

PSI, INC Research, Chiltern best with sites
Strategic outsourcing prioritizing, improving site relationships

Regulatory compliance an increasing burden on sites
Increased staff time, materials, storage eroding site operating profit

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs